يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"TANDEM-PRRT"', وقت الاستعلام: 1.43s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas

    المؤلفون: Elisabetta Perrone, Kriti Ghai, Aleksandr Eismant, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge, Andreas Kjaer, Richard P. Baum

    المصدر: Diagnostics, Vol 14, Iss 9, p 907 (2024)

    مصطلحات موضوعية: pancreas, neuroendocrine neoplasm, Peptide Receptor Radionuclide Therapy (PRRT), Lutetium-177, Actinium-225, TANDEM-PRRT, Medicine (General), R5-920

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2075-4418/14/9/907; https://doaj.org/toc/2075-4418

    URL الوصول: https://doaj.org/article/954bf3749ed14039a4459a0950bb60ba

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  3. 3
    Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, 90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects

    المؤلفون: Arpit Mitra, Sandip Basu, Sutapa Rakshit, Sharmila Banerjee, Rahul V Parghane, Trupti Upadhye Bannore

    المصدر: World Journal of Nuclear Medicine
    World Journal of Nuclear Medicine, Vol 20, Iss 1, Pp 73-81 (2021)

    مصطلحات موضوعية: lcsh:Medical physics. Medical radiology. Nuclear medicine, Tandem PRRT, lcsh:R895-920, Neuroendocrine tumors, 030218 nuclear medicine & medical imaging, Lesion, 177Lu-DOTATATE, 03 medical and health sciences, 0302 clinical medicine, duo-PRRT, medicine, Positron emission, medicine.diagnostic_test, 68Ga-DOTATATE PET-CT, Cumulative dose, business.industry, 90Y-DOTATATE, peptide receptor radionuclide therapy (PRRT), medicine.disease, Tolerability, 030220 oncology & carcinogenesis, Radionuclide therapy, Original Article, medicine.symptom, business, Nuclear medicine, Emission computed tomography, Progressive disease

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab71a97dec95fd1aa6974c5aa95834a
    http://europepmc.org/articles/PMC8034792

    Find this article in full text from ProQuest
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    كتاب

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Initial clinical evaluation of indigenous 90 Y-DOTATATE in sequential duo-PRRT approach ( 177 Lu-DOTATATE and 90 Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, 90 Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects.

    المؤلفون: Parghane RV; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Mitra A; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Bannore TU; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Rakshit S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Banerjee S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Basu S; Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Parel, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India.

    المصدر: World journal of nuclear medicine [World J Nucl Med] 2020 Oct 02; Vol. 20 (1), pp. 73-81. Date of Electronic Publication: 2020 Oct 02 (Print Publication: 2021).

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Thieme Country of Publication: Germany NLM ID: 101286955 Publication Model: eCollection Cited Medium: Print ISSN: 1450-1147 (Print) Linking ISSN: 14501147 NLM ISO Abbreviation: World J Nucl Med Subsets: PubMed not MEDLINE

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء